Facebook
Twitter
LinkedIn
Forward
2024 ASTRO Annual Refresher Course Credit Evaluation
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidisciplinary management of cancer patients. The course will review key evidence that forms the basis for current clinical practice guidelines and trends in new approaches. In addition, the course will cover implementation of hypofractionation in key disease sites as well as treatment of oligometastases and use of SBRT to improve outcomes for patients with metastatic disease. It will also provide hands-on experience in contouring for CNS, sarcoma, and head and neck. It will also inform on the emerging field of Artificial Intelligence in the clinic and the use of circulating tumor DNA in the treatment of select patients with cancer.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this live activity, participants should be able to:
- Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
- Safely utilize the latest radiation technologies to improve patient care.
- Describe the ways in which Artificial Intelligence can be implemented in the radiation oncology clinic to aid contouring, diagnosis, and management of patients.
- Appropriately and safely incorporate the treatment of oligometastases into clinical practice.
- Identify the ways in which ctDNA can be used in the management of patients with cancer.
Faculty:
A list of all meeting faculty and Individual presenter disclosures are linked to their names in the Schedule of Events.
Planning Committee:
A list of all meeting planning committee members and their individual disclosures can be found on the Planning Committee webpage.
Physicians
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants can access, print and save their certificate from the ASTRO Academy.
Physicists
An application will be submitted to the Commission on Accreditation of Medical Physics Education Program (CAMPEP) for Medical Physics Continuing Education Credits (MPCEC).
Available Credit
- 22.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 22.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 22.00 Certificate of AttendanceThis activity was designated for 22.00 AMA PRA Category 1 Credit™.
Price
To be eligible to receive continuing education credit, attendees must complete the online evaluation by Monday, May 20, 2024. Please only evaluate the sessions you attended.
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.
Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.